Non-IRA Functional Evaluation With AccuFFRangio in NSTE-ACS

Status Not yet recruiting

Clinical Trial Summary

This is a prospective, single-center clinical trial. AccuFFRangio (ArteryFlow Technology Co., Ltd., Hangzhou, China) is a novel method for evaluating the functional significance of coronary stenosis by computing the pressure in the vessel based on angiographic images. The purpose of this study is to investigate the diagnostic performance and prognostic ability of AccuFFRangio for non-IRA in NSTE-ACS patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Acute Coronary Syndrome
Coronary Artery Disease
Non ST Segment Elevation Acute Coronary Syndrome
Percutaneous Coronary Intervention

Clinical Trial Details

NCT number	NCT05202041
Study type	Interventional
Source	Wuhan Asia Heart Hospital
Contact	Dan Song, MD
Phone	+86-027-65796888
Email	songdan8300@163.com
Status	Not yet recruiting
Phase	N/A
Start date	February 15, 2022
Completion date	March 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04080700` - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting	`NCT03810599` - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study	N/A
Recruiting	`NCT05308719` - Nasal Oxygen Therapy After Cardiac Surgery	N/A
Recruiting	`NCT04242134` - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions	N/A
Completed	`NCT04556994` - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.	N/A
Recruiting	`NCT05023629` - STunning After Balloon Occlusion	N/A
Recruiting	`NCT04941560` - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed	`NCT04006288` - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease	Phase 4
Completed	`NCT01860274` - Meshed Vein Graft Patency Trial - VEST	N/A
Not yet recruiting	`NCT05366153` - Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer
Recruiting	`NCT03968809` - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting	`NCT03959072` - Cardiac Cath Lab Staff Radiation Exposure
Not yet recruiting	`NCT04647448` - Multisensor Array for the Localisation of Coronary Artery Stenosis (MALCAS)
Recruiting	`NCT05065073` - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography	Phase 4
Recruiting	`NCT04566497` - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.	N/A
Recruiting	`NCT04562805` - Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)	N/A
Recruiting	`NCT04310046` - Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial	N/A
Active, not recruiting	`NCT04677725` - NEtwork to Control ATherothrombosis (NEAT Registry)
Active, not recruiting	`NCT04483791` - DynamX Bioadaptor Hong Kong Registry	Phase 4
Completed	`NCT04375085` - DESyne X2 Post Market Follow-up Study	N/A